Filter
304
Text search:
mRNA
Featured
Recommendations
56
New Publications
8
Language
Document type
Guidelines
99
Fact sheets
64
Studies & Reports
38
No document type
32
Videos
29
Manuals
11
Resource Platforms
11
Strategic & Response Plan
8
Training Material
5
Infographics
3
Situation Updates
2
Brochures
1
Online Courses
1
Countries / Regions
Germany
23
Brazil
16
Russia
12
Global
10
Ukraine
8
Middle East and North Africa
7
Latin America and the Carribbean
7
India
6
Nigeria
4
Syria
4
Ecuador
4
Yemen
4
Lebanon
3
Mozambique
3
Argentina
3
Eastern Europe
3
Senegal
2
Mali
2
Uganda
2
Niger
2
Haiti
2
Somalia
2
South Sudan
2
China
2
South Africa
2
Sudan
2
Peru
2
Chile
2
Western and Central Europe
2
Africa
2
Kazakhstan
2
Belarus
2
Burkina Faso
1
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Ethiopia
1
Cameroon
1
Iraq
1
Jordan
1
Egypt
1
Chad
1
Kenya
1
Rwanda
1
Indonesia
1
Mauritania
1
Benin
1
Dominican Republic
1
Cuba
1
Colombia
1
Honduras
1
El Salvador
1
Bolivia
1
Libya
1
Angola
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
Venezuela
1
Congo-Brazzaville
1
Qatar
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
92
Clinical Guidelines
15
Public Health
8
Key Resources
8
Pharmacy & Technologies
4
Women & Child Health
3
Capacity Building
1
Toolboxes
COVID-19
198
Refugee
22
TB
9
HIV
6
Mental Health
5
Ebola
4
Conflict
4
Rapid Response
4
Pharmacy
3
NTDs
3
Health Financing Toolbox
3
NCDs
2
Zika
1
Specific Hazards
1
Global Health Education
1
AMR
1
Planetary Health
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no
...
Exciting news this week with @Pfizer reporting their mRNA vaccine is 90% effective, based on their Phase III clinical trial data. Dr. Tom looks inside the virus to break down how mRNA vaccines work,
...
updated version: 04/10/2021
Information about vaccine administration
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b
...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc
...
Myths & COVID-19 Vaccinations
recommended
Issue Brief no. 16. 20 Sept 2021.
Many studies have shown the effectiveness of vaccination against COVID-19 and that it protects against severe
illness. A high vaccination rate is needed to combat the pandemic worldwide. Due to misinformation and myths,
there is still a great hesitancy to vaccina
...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit mRNA-Impfstoffen –
Erklärung für die Formulare
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the vaccine, currently known as
...
обновленная версия от 04/10/2021
Информация о введении вакцин
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three clinical trial phases.
Part three focused on the ste
...
Qu’est-ce qu’un vaccin? Comment fonctionnent les vaccins ARNm contre la COVID-19 et quelle est leur importance? Regardez cette vidéo pour tout savoir sur les vaccins ARNm sûrs et efficaces contre la COViD-19
Cet article fait partie d’une série d’explications à propos de la mise au point et de la distribution des vaccins.
Available in English, French, Spanisch, Arabic, Chinese and Russian
